ATS 2024 Final Program

Click on the session title to view the speakers

220

TUESDAY • MAY 21

• apply new clinical research knowledge to clinical practice • apply new findings about key conditions in pulmonary, critical care and sleep • learn new strategies to manage the care of common conditions in pulmonary, critical care, and sleep The program will discuss general topics of interest to a broad group of providers, inside and outside of these subspecialties. The program is relevant to not only clinicians, but also to researchers and administrators. 9:15 Interstitial Lung Disease 9:37 Medical Education 9:59 Sepsis 10:23 Occupational/Environmental Lung Disease This session and the International Conference are supported CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE C2 DECENTRALIZED CLINICAL TRIALS: EASIER FOR PATIENTS AND PULMONOLOGISTS Assemblies on Clinical Problems; Allergy, Immunology and Inflammation; Behavioral and Health Services Research; Critical Care; Nursing; Sleep and Respiratory Neurobiology 9:15 a.m. - 10:45 a.m. San Diego Convention Center Room 6B (Upper Level) Target Audience Individuals who design and implement clinical trials, as well as end-users of information developed from clinical trials (patients, caregivers, clinicians, policymakers). Objectives At the conclusion of this session, the participant will be able to: • define decentralized clinical trials (DCTs) • describe the potential impact of DCTs on participant enrollment and generalizability of study results to real-world practice • identify examples of remote participant consent and monitoring of outcomes in DCTs by an independent medical educational grant from Boehringer IngelheimPharmaceuticals, Inc. All CMEsessions have been planned and implemented in accordancewith the AccreditationCriteria of theAccreditationCouncil for ContinuingMedical Education (ACCME ® ) and are free of the control of ineligible companies (formerly commercial interests).

We will explore the growing interest of decentralized clinical trials (which allow some or all trial-related activities to take place in participants’ homes or other convenient locations) instead of research sites from four perspectives: 1) regulator; 2) practicing clinician; 3) researcher; and, 4) funder. 9:15 Welcome and Session Overview 9:20 Clinical Trials: Why Are They So Difficult to Successfully Complete? 9:30 Decentralized Clinical Trials: FDA perspective 9:40 Moderated Q&A and Introduction of Next Speaker 9:45 Decentralized Clinical Trials: A Practicing Clinician Perspective 9:55 Decentralized Clinical Trials: Researcher Perspective About the Use of Remote Monitoring 10:05 Moderated Q&A and Introduction of Next Speaker 10:10 Division of Lung Disease / NHLBI Perspective 10:20 Moderated Q&A and Introduction of Next Speaker 10:25 Panel Discussion C3 PEDIATRIC CLINICAL CHEST ROUNDS Assembly on Pediatrics 9:15 a.m. - 10:45 a.m. San Diego Convention Center Room 6A (Upper Level) Target Audience Pediatric pulmonary clinicians and trainees (including students, physicians, advanced practice providers, nurses, therapists) interested in the diagnosis and management of challenging cases. Objectives At the conclusion of this session, the participant will be able to: • TBD depending on the selected cases. • TBD depending on the selected cases. • TBD depending on the selected cases. Pediatric Clinical Chest Rounds is an annual symposium focused on the diagnosis and management of 4 challenging cases, selected from reports submitted to the PEDS Assembly. Each case is presented by a trainee (typically a Ped Pulm fellow), CLINICAL CLINICAL TOPICS IN PULMONARY MEDICINE

ATS 2024 Conference Program • San Diego, CA